Merck & Co.'s COVID-19 therapy pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus, and it would soon ask health officials in the U.S. and around the world to authorize its use, the company said. Newsday's Cecilia Dowd reports. Credit: Kendal Rodriguez; Merck

YOU'VE BEEN SELECTED

FOR OUR BEST OFFER ONLY 25¢ for 5 months

Unlimited Digital Access.

cancel anytime.